HSBC Mutual FundIndex Funds - Equity Funds3.9 years
The scheme seeks to invest in stocks comprising the Nifty Next 50 index in the same proportion as in the index with the objective of achieving returns equivalent to the Total Returns Index of Nifty Next 50 index by minimizing the performance difference between the benchmark index and the scheme.
Buying brief
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 30 Oct 2026
Stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
In three lines
Fits if · The fund beat the category median in 81% of rolling 3-year windows.
Fits if · Three-year return is above the category median.
Prefer peers if · Prefer Aditya Birla Sun Life BSE 500 Quality 50 Index Fund if you want a same-category peer with stronger evidence.
Buy checklist
History depth
Watch
3.9 years - usable, still building a track record.
Engine status
Watch
Recent evidence is mixed. Compare peers before increasing exposure.
Expense ratio
Pass
0.46% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -26.6%. Ask whether you can hold through a similar fall.
Vs category
Pass
81% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
Pass
Rajeesh Nair · 3.1 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 32.8% of the portfolio.
Same-category peers are preloaded into compare when available.
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 27%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
Monitor is recent mixed evidence - keep the SIP unless the buying brief says prefer peers, then swap with intent.
NAV
Path not in current snapshots
n/a
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Peak to trough from a running NAV high, with the path and recovery episodes.
Drawdown
Path not in current snapshots
n/a
27 Sept 2024 – open
Trough 28 Feb 2025 · not recovered
-26.6%
8 Dec 2022 – 5 Jul 2023
Trough 28 Mar 2023 · recovered in 99 days
-16.0%
3 Jun 2024 – 13 Jun 2024
Trough 4 Jun 2024 · recovered in 9 days
-9.3%
11 Sept 2023 – 16 Nov 2023
Trough 26 Oct 2023 · recovered in 21 days
-7.8%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
68
Vs category
70
Consistency
70
Risk-adjusted
47
Drawdown
34
Mean
58
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Buying stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
Why this status
No status reasons yet. History is still thin.
Supporting reads
31 Aug 2026 · 51 holdings · top 10 are 32.8%.
Divi's Laboratories Ltd
Healthcare
4.7%
TVS Motor Company Ltd
Consumer Discretionary
4.0%
Tata Motors Ltd
Industrials
3.9%
Hindustan Aeronautics Ltd
Industrials
3.6%
Adani Power Ltd
Energy & Utilities
3.2%
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
Aditya Birla Sun Life Mutual Fund
Caveat: Lower trailing returns
Axis Mutual Fund
Caveat: Lower trailing returns
Axis Mutual Fund
Caveat: Lower trailing returns
Jio BlackRock Mutual Fund
Caveat: Lower trailing returns
Zerodha Mutual Fund
Caveat: Lower trailing returns
HSBC Mutual FundIndex Funds - Equity Funds3.9 years
The scheme seeks to invest in stocks comprising the Nifty Next 50 index in the same proportion as in the index with the objective of achieving returns equivalent to the Total Returns Index of Nifty Next 50 index by minimizing the performance difference between the benchmark index and the scheme.
Buying brief
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 30 Oct 2026
Stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
In three lines
Fits if · The fund beat the category median in 81% of rolling 3-year windows.
Fits if · Three-year return is above the category median.
Prefer peers if · Prefer Aditya Birla Sun Life BSE 500 Quality 50 Index Fund if you want a same-category peer with stronger evidence.
Buy checklist
History depth
Watch
3.9 years - usable, still building a track record.
Engine status
Watch
Recent evidence is mixed. Compare peers before increasing exposure.
Expense ratio
Pass
0.46% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -26.6%. Ask whether you can hold through a similar fall.
Vs category
Pass
81% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
Pass
Rajeesh Nair · 3.1 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 32.8% of the portfolio.
Same-category peers are preloaded into compare when available.
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 27%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
Monitor is recent mixed evidence - keep the SIP unless the buying brief says prefer peers, then swap with intent.
NAV
30 Oct 2026 · -3.1% over 1Y
29.7476
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Peak to trough from a running NAV high, with the path and recovery episodes.
Drawdown
30 Oct 2026
-12.4%
27 Sept 2024 – open
Trough 28 Feb 2025 · not recovered
-26.6%
8 Dec 2022 – 5 Jul 2023
Trough 28 Mar 2023 · recovered in 99 days
-16.0%
3 Jun 2024 – 13 Jun 2024
Trough 4 Jun 2024 · recovered in 9 days
-9.3%
11 Sept 2023 – 16 Nov 2023
Trough 26 Oct 2023 · recovered in 21 days
-7.8%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
68
Vs category
70
Consistency
70
Risk-adjusted
47
Drawdown
34
Mean
58
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Buying stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
Why this status
No status reasons yet. History is still thin.
Supporting reads
31 Aug 2026 · 51 holdings · top 10 are 32.8%.
Divi's Laboratories Ltd
Healthcare
4.7%
TVS Motor Company Ltd
Consumer Discretionary
4.0%
Tata Motors Ltd
Industrials
3.9%
Hindustan Aeronautics Ltd
Industrials
3.6%
Adani Power Ltd
Energy & Utilities
3.2%